| Literature DB >> 36231509 |
Elżbieta Wołejko1, Bożena Łozowicka2, Agata Jabłońska-Trypuć1, Marta Pietruszyńska3, Urszula Wydro1.
Abstract
Chlorpyrifos (CPF) was the most frequently used pesticide in food production in the European Union (EU) until 2020. Unfortunately, this compound is still being applied in other parts of the world. National monitoring of pesticides conducted in various countries indicates the presence of CPF in soil, food, and water, which may have toxic effects on consumers, farmers, and animal health. In addition, CPF may influence changes in the population of fungi, bacteria, and actinomycete in soil and can inhibit nitrogen mineralization. The mechanisms of CPF activity are based on the inhibition of acetylcholinesterase (AChE) activity. This compound also exhibits reproductive toxicity, neurotoxicity, and genotoxicity. The problem seems to be the discrepancy between the actual observations and the final conclusions drawn for the substance's approval in reports presenting the toxic impact of CPF on human health. Therefore, this influence is still a current and important issue that requires continuous monitoring despite its withdrawal from the market in the EU. This review traces the scientific reports describing the effects of CPF resulting in changes occurring in both the environment and at the cellular and tissue level in humans and animals. It also provides an insight into the hazards and risks to human health in food consumer products in which CPF has been detected.Entities:
Keywords: CPF; environment; risk assessment; toxicity
Mesh:
Substances:
Year: 2022 PMID: 36231509 PMCID: PMC9566616 DOI: 10.3390/ijerph191912209
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1The occurrence and permeation of CPF in the environment.
Figure 2Biotransformation pathways of CPF in hepatocytes [49].
Figure 3Undesirable health effects of exposure to CPF.
Reports of the studies of mammalian exposure to CPF.
| Species | Dosage/Route/Type | Effect | Ref. |
|---|---|---|---|
| Rats | Initial dose of 60 mg/kg, followed every 2 months with a single dose of 45 mg/kg | Deficits in learning | [ |
| Rat pups on PND 1–6 | Diet at a daily dose1234567of 1.5 or 3.0 mg/kg (by gavage in corn oil) | Decreased levels of mRNA for nerve growth factor, muscarinic M1, and reelin receptors, and an increase in glial fibrillary acidic protein mRNA and inhibited brain AChE activity | [ |
| Rat pups PND 11–16 | Daily dose 0.5, 0.75, and 1.0 mg/kg b.w. | For brain AChE inhibition being 1.0 mg/kg b.w./day | [ |
| 3-month-old Long-Evans rats | Diet at a daily dose of 0, 1, or 5 mg/kg for 1 year | No effects on learning or memory | [ |
| 3-week-old male Wistar rats | Daily dose 0.30 mg/kg b. w. normal fat | Significant increase in various hormones such as pancreatic polypeptide, gastric inhibitory polypeptide and monocyte chemoattractant protein 1 and tumor necrosis factor α | [ |
| Daily dose 0.30 mg/kg b.w. high fat | Significant influence on the gut microbiome and increased glucagon-like peptide-1 | ||
| Pregnant rats from GD 6 to PND 10 | Daily dose at 0.3, 1, and 5 mg/kg b.w. | 5 mg/kg: led to a decrease in pup weights and viability index (%) and presented cholinergic signs (fasciculatins, ataxia, tremors, etc.)12345670.3 and 1 mg/kg: 8–11% decrease in the cerebellum height to brain weight ratio | [ |
| Pregnant rats from GD 14–20 | 10 mg/kg CPF (oral) | Reduced body mass gain in mothers during treatment and increased body weight gain in male offspring from PND42 | [ |
| Adult Wistar rats weighing 150–200 g | 10 mg/kg b.w. 28-day oral exposure | decreased GSH-Px activity in blood | [ |
| Male Sprague-Dawley adult rats | Doses of 0.1, 1, and 10 mg/kg b.w. once daily for 7 days (sunflower oil) | Inhibition of AChE activity by approximately 20% | [ |
| CD-1 mice from GD 15–18 | 3 or 6 mg/kg/day (peanut oil) | 3 mg/kg: approximately 10% brain AChE inhibition12345676 mg/kg: 40% brain AChE inhibition 24 h after last dose | [ |
| Pregnant CD-1 mice from GD 14–17 | 6 mg/kg CPF (oral) | Concentration of 3,5,6-TCP found in the brains of fetuses was 250 ng/g and revealed decreased cognition in males and females | [ |
| Pregnant guinea pigs starting approximately GD 53–55 | 25 mg/kg/day formulated in peanut oil, 10th day | Decrease in AChE activity in red blood cells by approximately 75% | [ |
| 3-week-old male C57Bl/6 and CD-1 (ICR) mice | diet at daily doses of 5 mg/kg (dissolved in corn oil) for 12 weeks | Can disturb glucose homeostasis and induce insulin resistance and effects on intestinal inflammation | [ |
| Neonatal mice PND 10 | a single oral dose (0.1, 1.0 or 5 mg/kg b.w.) | Induced effects are not related to the classical mechanism of acute cholinergic hyperstimulation, as the AChE inhibition level (8–12%) remained below the threshold required to cause systemic toxicity | [ |
AChE—acetylcholinesterase; GD—gestational days; PND—postnatal day; 3,5,6-TCP—urinary biomarker 3,5,6-trichloro-2-pyridinol; GSH-Px—glutathione peroxidase; body weight—b.w.
Figure 4Occurrence of CPF residues in food in various parts of the world [37,158,166,167,168].